Covered recipient · General Payments record
SHELLEY ERIN DURHAM
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2021
$650.83
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $416.97 | 24 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $107.17 | 5 |
| Novo Nordisk AS | $104.23 | 7 |
| Lilly USA, LLC | $45.40 | 2 |
| Allergan Inc. | $37.94 | 2 |
| Amgen Inc. | $27.74 | 2 |
| GlaxoSmithKline, LLC. | $22.09 | 1 |
| Merck Sharp & Dohme Corporation | $18.56 | 1 |
| Alfasigma USA, Inc. | $15.62 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.40 | 1 |
| Genentech USA, Inc. | $11.75 | 1 |
| EISAI INC. | $11.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2021 20192020
Record-level detail is published for PY2021; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $16.01 | 03/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794388459 | CMS |
| AbbVie Inc. | $20.26 | 04/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794388461 | CMS |
| AbbVie Inc. | $28.20 | 04/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794388463 | CMS |
| AbbVie Inc. | $17.70 | 05/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794388465 | CMS |
| AbbVie Inc. | $25.00 | 07/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794388467 | CMS |
| Alfasigma USA, Inc. | $15.62 | 05/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 853044359 | CMS |
| Allergan, Inc. | $18.13 | 01/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 792758045 | CMS |
| Allergan, Inc. | $19.81 | 01/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 792758047 | CMS |
| Amgen Inc. | $12.65 | 03/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825786613 | CMS |
| Amgen Inc. | $15.09 | 04/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825786617 | CMS |
| Eisai Inc. | $11.07 | 07/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 817962715 | CMS |
| Genentech USA, Inc. | $11.75 | 02/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 835977173 | CMS |
| GlaxoSmithKline, LLC. | $22.09 | 05/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802212111 | CMS |
| Lilly USA, LLC | $22.59 | 01/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818753117 | CMS |
| Lilly USA, LLC | $22.81 | 02/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818747113 | CMS |
| Merck Sharp & Dohme Corporation | $18.56 | 01/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848365945 | CMS |
| Novartis Pharmaceuticals Corporation | $15.40 | 05/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 812665955 | CMS |
| Novo Nordisk Inc | $15.66 | 01/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811042703 | CMS |
| Novo Nordisk Inc | $11.40 | 01/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811160611 | CMS |
| Novo Nordisk Inc | $18.36 | 03/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810925489 | CMS |
| Novo Nordisk Inc | $14.77 | 04/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811160619 | CMS |
| Novo Nordisk Inc | $12.23 | 04/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810965045 | CMS |
| Novo Nordisk Inc | $15.34 | 06/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811121807 | CMS |
| Novo Nordisk Inc | $16.47 | 07/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811160627 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.